Cytomx Thera (CTMX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Sales | 38,093 | 33,432 | 25,115 | 41,463 | 26,607 |
| Gross Profit | 38,093 | 33,432 | 25,115 | 41,463 | 26,607 |
| Operating Expenses | 20,414 | 29,321 | 33,567 | 29,806 | 27,213 |
| Operating Income | 17,679 | 4,111 | -8,452 | 11,657 | -606 |
| Other Income | 1,260 | 1,686 | 1,969 | 2,183 | 2,512 |
| Pre-tax Income | 18,939 | 5,797 | -6,483 | 13,840 | 1,906 |
| Income Tax | 63 | 61 | 51 | 49 | 1,069 |
| Net Income Continuous | 18,876 | 5,736 | -6,534 | 13,791 | 837 |
| Net Income | $18,876 | $5,736 | $-6,534 | $13,791 | $837 |
| EPS Basic Total Ops | 0.22 | 0.07 | -0.08 | 0.17 | 0.02 |
| EPS Basic Continuous Ops | 0.22 | 0.07 | -0.08 | 0.17 | 0.02 |
| EPS Diluted Total Ops | 0.22 | 0.07 | -0.08 | 0.17 | 0.02 |
| EPS Diluted Continuous Ops | 0.22 | 0.07 | -0.08 | 0.17 | 0.02 |
| EPS Diluted Before Non-Recurring Items | 0.22 | 0.07 | -0.08 | N/A | N/A |
| EBITDA(a) | $17,305 | $3,320 | $-9,431 | $10,258 | $-2,346 |